What is the rationale for administering Ryzodeg (insulin degludec/insulin aspart) twice daily?

Rationale for Twice-Daily Ryzodeg Dosing

Ryzodeg (IDegAsp) is given twice daily when once-daily dosing fails to adequately control postprandial glucose throughout the day, particularly when the evening meal requires additional prandial coverage beyond what a single morning dose can provide.

When to Use Twice-Daily Dosing

The primary indication for splitting IDegAsp to twice-daily administration is inadequate glycemic control on once-daily dosing, specifically when:

• A1C remains above goal despite optimal titration of once-daily dosing 1
• Evening/dinner postprandial glucose is elevated while fasting glucose is controlled
• The patient has two substantial meals with significant carbohydrate content that require prandial insulin coverage 1

The Pharmacologic Logic

IDegAsp combines:

• Insulin degludec (70%): Ultra-long-acting basal component (>42 hour duration)
• Insulin aspart (30%): Rapid-acting prandial component (3-5 hour duration)

When given once daily, the rapid-acting aspart component only covers ONE meal effectively. The second daily dose is needed to provide prandial coverage for a second major meal, not because the basal component requires twice-daily dosing 2.

Clinical Evidence Supporting Twice-Daily Dosing

Twice-daily IDegAsp demonstrates superior outcomes compared to other premixed insulins:

• 47% lower nocturnal hypoglycemia and 43% lower overall hypoglycemia versus biphasic insulin aspart 30 (BIAsp30) twice daily 3
• Superior fasting plasma glucose control compared to BIAsp30 twice daily 4
• Effective A1C reduction (from 10.5% to 7.98% at 12 months) when switching from basal-bolus therapy, with fewer injections and lower total insulin doses 5

Dosing Strategy for Twice-Daily Regimen

Critical point: The twice-daily split does NOT need to be 50:50 1. Instead:

• Dose distribution should match carbohydrate content of the two main meals
• If breakfast has more carbohydrates → larger morning dose
• If dinner has more carbohydrates → larger evening dose
• Adjust each dose independently based on pre-meal and 2-hour postprandial glucose readings

Practical Titration Approach

Starting from once-daily:

1. Identify the second major meal requiring coverage (usually dinner)
2. Split the total daily dose based on meal carbohydrate distribution (not automatically 50:50)
3. Titrate each injection separately weekly based on:
   • Pre-meal glucose for the basal component
   • 2-hour postprandial glucose for the prandial component 1

Common Pitfall to Avoid

Do not assume twice-daily dosing means equal splitting. The flexible dosing is a key advantage of IDegAsp—the morning dose might be 40 units while the evening dose is 25 units, depending on meal patterns. This differs from traditional premixed insulins that typically require more rigid 50:50 or 2/3-1/3 distribution 6.

Comparison to Standard Intensification

The 2025 ADA guidelines suggest intensifying from basal insulin by adding prandial insulin or switching to premixed insulin 6. Twice-daily IDegAsp serves as a middle ground, providing:

• Fewer injections than basal-bolus (2 vs 4-5 daily)
• More flexibility than traditional premixed insulins (doses can be adjusted independently and don't require 50:50 split)
• Lower hypoglycemia risk than traditional premixed insulins 3, 4